Posts Tagged ‘CBD’

Researchers recently solved a major gap in scientific literature by using mobile software technology to measure the real-time effects of actual cannabis-based products used by millions of people every day.

https://www.sciencedaily.com/releases/2019/02/190226112353.htm

 

AuntieBS

Advertisements

“No stems, no seeds that you don’t need, Acapulco Gold is bad-ass weed”, to plagiarize a jingle from Cheech and Chong, almost 50 years ago.  Never mind stems and seeds, or even bad-ass weed, but learn about cannabidiol– CBD.  It is one of the main cannabinoids that is not psychoactive but has powerful medical properties.  It is a very good anti-inflammatory agent.  Many seniors use it in ointment for arthritic hands, elbows, shoulders, even backs.  CBD also has anti-cancer properties and while rumors and anecdotes abound, scientific research has shown it to be effective for gliomas– a specific type of brain cancer.  Now, it may be useful for eye and vision issues:

https://www.getholistichealth.com/77732/how-cbd-oil-can-improve-your-eyesight/

AuntieBS

https://www.sciencedaily.com/releases/2018/08/180830113004.htm

 

Cannabidiol (CBD) may be effective in treating depression.  Note that CBD is not intoxicating, suggesting that it may be used without interfering with normal activities.

 

AuntieBS

https://www.consumerreports.org/marijuana/what-is-cbd-what-to-know-about-this-cannabis-product/

 

newatlas.com/australian-cannabis-chronic-pain-study/55298/

I have first hand knowledge that this is untrue and was likely funded by Big Pharma to cast doubt about a plant that can reduce opiate use and promote sleep, not to mention that CBD is one of the most powerful anti-inflammatory drugs available.  The blatant lies to get funding from Big Pharma just amaze me– scientists selling out the truth for money!

AuntieBS

Although THC and CBD are popular cannabinoids, there are a handful of cannabis strains that contain higher than average levels of esoteric cannabinoids like CBG, CBN, and CBC.

Source: These Cannabis Strains All Have Unique Cannabinoids | Leafly

NORML’s mission is to move public opinion sufficiently to legalize the responsible use of marijuana by adults, and to serve as an advocate for consumers to assure they have access to high quality marijuana that is safe, convenient and affordable.

Source: NORML.org – Working to Reform Marijuana Laws – NORML.org – Working to Reform Marijuana Laws

Medical Marijuana Legalization Associated With Fewer Opioid-Related Hospitalizations

Medical Marijuana - Fewer Opioid-Related HospitalizationsSan Diego, CA: The enactment of statewide legislation permitting medical cannabis access by qualified patients is associated with a reduction in opioid-related hospitalization, according to data published online ahead of print in the journal Drug and Alcohol Dependence.

A researcher from the University of California at San Diego assessed the association between medical cannabis laws and hospitalizations related to opioid pain relievers. The author reported both immediate and longer-term reductions in opioid-related hospitalization following changes in law.

“This study demonstrated significant reductions on OPR- (opioid pain reliever) related hospitalizations associated with the implementation of medical marijuana policies. … We found reductions in OPR-related hospitalizations immediately after the year of policy implementation as well as delayed reductions in the third post-policy year.”

The author also dismissed contentions that liberalized marijuana laws were associated with any subsequent increase in marijuana-related hospital admissions, concluding: “While the interpretation of the results should remain cautious, this study suggested that medical marijuana policies were not associated with marijuana-related hospitalizations. Instead, the policies were unintendedly associated with substantial reductions in OPR related hospitalizations.”

The findings are consistent with those of other studies reporting that medical cannabis legalization is associated with lower rates of opioid abuse, mortality, and prescription drug spending.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever,” appears in Drug and Alcohol Dependence.

Israeli Cabinet Endorses Marijuana Decriminalization Plan

Israeli Marijuana Decriminalization PlanJerusalem, Israel: Israeli lawmakers have signed off on legislation decriminalizing offenses involving the possession of personal use quantities of marijuana.

Under the new policy, first and second time possession offenders will face a fine, but no criminal penalties.

“The Cabinet approval is an important step on the way to implementing the new policy that will put emphasis on explaining and treating rather than on criminal enforcement,” explained Israeli Public Security Minister Gilad Erdan.

The medical production and distribution of cannabis for medical purposes is already legally permitted in Israel as part of a program governed by the Ministry of Health. About 25,000 Israelis receive medical marijuana as part of this program.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org.

Study: CBD-Dominant Cannabis Extracts Reduce Seizure Frequency

CBD Cannabis Extracts Reduce SeizuresFalmouth, ME: The administration of whole-plant cannabis extracts rich in the cannabinoid cannabidol (CBD) is associated with reduced seizure frequency in patients with refractory epilepsy, according to data published online ahead of print in the journal Epilepsy & Behavior.

Researchers performed a retrospective chart review of the clinical records of 272 patients who were taking whole-plant CBD extracts.

Eighty-six percent of those treated observed some clinical benefit (a reduction in seizure frequency) while ten percent experienced a complete clinical response. The remaining patients were either not responsive to treatment or reported an exacerbation of seizures during therapy.

Beneficial side effects, such as improved mood, better sleep quality, and increased appetite were reported.

“The cannabinoids’ novel mechanisms of action are an attractive consideration for possible seizure control,” authors concluded. “In patients with refractory epilepsy that have a low likelihood of responding to a subsequent AED (anti-epileptic drug), a trial of artisanal cannabis formulas may be indicated.”

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “The current status of artisanal cannabis for the treatment of epilepsy in the United States,” appears in Epilepsy & Behavior. Additional data regarding the efficacy of cannabinoids as anticonvulsants appears in NORML’s library.

Pennsylvania: Auditor General Says State Lawmakers Should Regulate The Marijuana Market

Pennsylvania Should Regulate MarijuanaHarrisburg, PA: Pennsylvania’s auditor general on Monday publicly advocated for the legalization and taxation of retail marijuana sales, arguing that such a policy would bring new jobs and tax revenue to the state.

Speaking at a news conference at the state capitol, Auditor General Eugene DePasquale said: “The regulation and taxation of the marijuana train has rumbled out of the station, and it is time to add a stop in the Commonwealth of Pennsylvania. I make this recommendation because it is a more sane policy to deal with a critical issue facing the state. Other states are already taking advantage of the opportunity for massive job creation and savings from reduced arrests and criminal prosecutions. In addition, it would generate hundreds of millions of dollars each year that could help tackle Pennsylvania’s budget problems.”

However, Gov. Tom Wolf said that state lawmakers should not go forward with regulating the adult use marijuana market at this time. Instead, he expressed support for decriminalizing the possession and personal use of the plant.

For more information, please contact Justin Strekal, NORML Political Director, at (202) 483-5500 or visit: http://www.phillynorml.org/.

NORML and the NORML Foundation: 1100 H Street NW, Suite 830, Washington DC, 20005
Tel: (202) 483-5500 • Fax: (202) 483-0057 • Email: norml@norml.org